Axonics (AXNX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

AXNX Stock Forecast

Axonics stock forecast is as follows: an average price target of $71.00 (represents a 0.03% upside from AXNX’s last price of $70.98) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

AXNX Price Target

The average price target for Axonics (AXNX) is $71.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $71.00 to $71.00. This represents a potential 0.03% upside from AXNX's last price of $70.98.

AXNX Analyst Ratings

Buy

According to 6 Wall Street analysts, Axonics's rating consensus is 'Buy'. The analyst rating breakdown for AXNX stock is 0 'Strong Buy' (0.00%), 4 'Buy' (66.67%), 2 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Axonics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Sep 19, 2024	Adam Maeder	Piper Sandler	-	-	2.44%	0.03%

Row per page

Go to

The latest Axonics stock forecast, released on Sep 19, 2024 by Adam Maeder from Piper Sandler, set a price target of $71.00, which represents a 2.44% increase from the stock price at the time of the forecast ($69.31), and a 0.03% increase from AXNX last price ($70.98).

Axonics Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	1
Avg Price Target	-	$71.00	$71.00
Last Closing Price	$70.98	$70.98	$70.98
Upside/Downside	-100.00%	0.03%	0.03%

In the current month, the average price target of Axonics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Axonics's last price of $70.98. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 19, 2024	Piper Sandler	Neutral	Neutral	Hold
Feb 29, 2024	Wells Fargo	Sector Perform	Sector Perform	Hold
Jul 13, 2023	KeyBanc		Overweight	Initialise
Mar 24, 2023	Needham		Buy	Upgrade
Oct 05, 2022	Piper Sandler	Overweight	Overweight	Hold
Aug 02, 2022	Morgan Stanley	Overweight	Overweight	Hold
Feb 25, 2022	SVB Leerink	Outperform	Outperform	Hold
Feb 25, 2022	Morgan Stanley	Overweight	Overweight	Hold

Row per page

Go to

Axonics's last stock rating was published by Piper Sandler on Sep 19, 2024. The company gave AXNX a "Neutral" rating, the same as its previous rate.

Axonics Financial Forecast

Axonics Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$93.10M	$22.70M	$70.65M	$85.92M	$70.38M	$68.98M	$48.42M	$53.13M	$46.91M	$45.87M	$34.37M	$34.78M	$35.24M	$15.21M	$26.30M	$9.95M	$1.31M
Avg Forecast	$180.99M	$159.71M	$157.36M	$125.39M	$157.34M	$137.31M	$135.69M	$108.46M	$128.89M	$113.36M	$112.83M	$89.79M	$107.33M	$89.59M	$86.45M	$64.43M	$82.22M	$63.54M	$59.60M	$45.37M	$50.37M	$48.39M	$39.82M	$27.94M	$35.29M	$22.95M	$5.19M	$14.64M	$10.00M	$1.42M
High Forecast	$182.49M	$161.03M	$158.66M	$126.43M	$158.64M	$138.44M	$136.81M	$109.35M	$130.11M	$113.55M	$112.83M	$89.79M	$107.50M	$89.59M	$87.16M	$64.96M	$82.90M	$63.54M	$59.60M	$45.37M	$50.37M	$48.39M	$39.82M	$27.94M	$35.29M	$22.95M	$5.19M	$14.64M	$10.00M	$1.42M
Low Forecast	$178.96M	$157.92M	$155.59M	$123.98M	$155.57M	$135.77M	$134.16M	$107.24M	$127.66M	$113.17M	$112.83M	$89.79M	$107.01M	$89.59M	$85.48M	$63.70M	$81.30M	$63.54M	$59.60M	$45.37M	$50.37M	$48.39M	$39.82M	$27.94M	$35.29M	$22.95M	$5.19M	$14.64M	$10.00M	$1.42M
# Analysts	1	1	1	1	1	1	1	1	2	1	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	5	4	4	3
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.04%	0.26%	1.10%	1.04%	1.11%	1.16%	1.07%	1.05%	0.97%	1.15%	1.23%	0.99%	1.54%	2.93%	1.80%	0.99%	0.92%

Axonics's average Quarter revenue forecast for Dec 23 based on 8 analysts is $107.33M, with a low forecast of $107.01M, and a high forecast of $107.50M. AXNX's average Quarter revenue forecast represents a 15.29% increase compared to the company's last Quarter revenue of $93.10M (Sep 23).

Axonics EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	5	4	4	3
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-687.00K	$22.31M	$-8.61M	$2.96M	$-4.32M	$-5.97M	$-20.46M	$-15.11M	$-13.80M	$-13.34M	$-20.48M	$-10.41M	$-8.29M	$-18.91M	$-13.68M	$-21.88M	$-24.11M
Avg Forecast	$-70.71M	$-62.40M	$-61.48M	$-48.99M	$-61.47M	$-53.64M	$-53.01M	$-42.37M	$-50.36M	$-44.29M	$-44.08M	$-29.87M	$-41.93M	$-35.00M	$-33.77M	$-27.15M	$-17.97M	$-23.97M	$-22.49M	$-24.68M	$-19.01M	$-18.26M	$-15.03M	$-12.48M	$-13.32M	$-8.66M	$-1.96M	$-17.56M	$-3.77M	$-534.80K
High Forecast	$-69.92M	$-61.70M	$-60.79M	$-48.44M	$-60.78M	$-53.04M	$-52.42M	$-41.90M	$-49.88M	$-44.22M	$-44.08M	$-23.89M	$-41.81M	$-35.00M	$-33.39M	$-21.72M	$-14.38M	$-23.97M	$-22.49M	$-19.75M	$-19.01M	$-18.26M	$-15.03M	$-9.99M	$-13.32M	$-8.66M	$-1.96M	$-14.05M	$-3.77M	$-534.80K
Low Forecast	$-71.30M	$-62.91M	$-61.99M	$-49.39M	$-61.98M	$-54.09M	$-53.45M	$-42.72M	$-50.83M	$-44.36M	$-44.08M	$-35.84M	$-42.00M	$-35.00M	$-34.05M	$-32.58M	$-21.57M	$-23.97M	$-22.49M	$-29.62M	$-19.01M	$-18.26M	$-15.03M	$-14.98M	$-13.32M	$-8.66M	$-1.96M	$-21.07M	$-3.77M	$-534.80K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.02%	-0.66%	0.32%	-0.16%	0.18%	0.27%	0.83%	0.80%	0.76%	0.89%	1.64%	0.78%	0.96%	9.66%	0.78%	5.80%	45.08%

4 analysts predict AXNX's average Quarter EBITDA for Sep 23 to be $-35.00M, with a high of $-35.00M and a low of $-35.00M. This is -256.91% lower than Axonics's previous annual EBITDA (Jun 23) of $22.31M.

Axonics Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	5	4	4	3
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.93M	$-7.34M	$-9.25M	$665.00K	$-16.25M	$-21.44M	$-22.67M	$-15.17M	$-17.25M	$-25.15M	$-22.50M	$-11.35M	$-9.17M	$-19.78M	$-14.62M	$-22.75M	$-25.01M
Avg Forecast	$21.59M	$11.99M	$12.08M	$-1.54M	$15.07M	$8.17M	$14.65M	$-2.38M	$14.56M	$5.74M	$5.02M	$-33.09M	$3.30M	$-2.61M	$-6.02M	$-30.08M	$-18.04M	$-23.84M	$-28.10M	$-27.35M	$-18.41M	$-21.94M	$-25.15M	$-13.72M	$-15.82M	$-26.88M	$-33.27M	$-18.76M	$-36.68M	$-38.28M
High Forecast	$21.83M	$12.11M	$12.21M	$-1.52M	$15.23M	$8.26M	$14.80M	$6.56M	$20.69M	$5.97M	$5.02M	$-26.47M	$5.49M	$-2.57M	$-5.93M	$-24.06M	$-14.43M	$-23.84M	$-28.10M	$-21.88M	$-18.41M	$-21.94M	$-25.15M	$-10.98M	$-15.82M	$-26.88M	$-33.27M	$-15.01M	$-36.68M	$-38.28M
Low Forecast	$21.28M	$11.81M	$11.91M	$-1.56M	$14.85M	$8.05M	$14.43M	$-8.94M	$9.96M	$5.50M	$5.01M	$-39.71M	$1.10M	$-2.64M	$-6.08M	$-36.10M	$-21.64M	$-23.84M	$-28.10M	$-32.81M	$-18.41M	$-21.94M	$-25.15M	$-16.47M	$-15.82M	$-26.88M	$-33.27M	$-22.51M	$-36.68M	$-38.28M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.51%	1.22%	0.31%	-0.04%	0.68%	0.76%	0.83%	0.82%	0.79%	1.00%	1.64%	0.72%	0.34%	0.59%	0.78%	0.62%	0.65%

Axonics's average Quarter net income forecast for Dec 23 is $3.30M, with a range of $1.10M to $5.49M. AXNX's average Quarter net income forecast represents a -16.10% decrease compared to the company's last Quarter net income of $3.93M (Sep 23).

Axonics SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	5	4	4	3
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$59.32M	$54.98M	$54.82M	$54.09M	$49.14M	$49.95M	$43.08M	$40.74M	$36.83M	$33.45M	$27.55M	$24.87M	$22.83M	$19.76M	$24.22M	$21.84M	$20.87M
Avg Forecast	$284.23M	$250.82M	$247.12M	$196.92M	$247.09M	$215.63M	$213.09M	$170.33M	$202.41M	$178.03M	$177.20M	$62.88M	$168.56M	$140.70M	$135.76M	$57.16M	$48.45M	$99.78M	$93.60M	$71.25M	$79.10M	$75.99M	$62.54M	$16.80M	$55.42M	$36.04M	$8.15M	$22.99M	$15.70M	$2.23M
High Forecast	$286.58M	$252.89M	$249.16M	$198.55M	$249.13M	$217.41M	$214.85M	$171.73M	$204.33M	$178.32M	$177.20M	$75.45M	$168.82M	$140.70M	$136.88M	$68.59M	$58.14M	$99.78M	$93.60M	$71.25M	$79.10M	$75.99M	$62.54M	$20.16M	$55.42M	$36.04M	$8.15M	$22.99M	$15.70M	$2.23M
Low Forecast	$281.04M	$248.00M	$244.34M	$194.71M	$244.31M	$213.21M	$210.69M	$168.41M	$200.48M	$177.73M	$177.20M	$50.30M	$168.05M	$140.70M	$134.24M	$45.73M	$38.76M	$99.78M	$93.60M	$71.25M	$79.10M	$75.99M	$62.54M	$13.44M	$55.42M	$36.04M	$8.15M	$22.99M	$15.70M	$2.23M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.42%	0.41%	0.96%	1.12%	0.49%	0.53%	0.60%	0.52%	0.48%	0.53%	1.64%	0.45%	0.63%	2.42%	1.05%	1.39%	9.38%

Axonics's average Quarter SG&A projection for Dec 23 is $168.56M, based on 8 Wall Street analysts, with a range of $168.05M to $168.82M. The forecast indicates a 184.14% rise compared to AXNX last annual SG&A of $59.32M (Sep 23).

Axonics EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	5	4	4	3
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$0.08	$-0.15	$-0.19	$0.01	$-0.34	$-0.47	$-0.50	$-0.34	$-0.38	$-0.59	$-0.57	$-0.29	$-0.24	$-0.54	$-0.43	$-0.75	$-0.89
Avg Forecast	$0.42	$0.23	$0.24	$-0.03	$0.29	$0.16	$0.29	$-0.05	$0.28	$0.11	$0.10	$-0.06	$0.06	$-0.05	$-0.12	$-0.29	$-0.24	$-0.47	$-0.55	$-0.63	$-0.36	$-0.43	$-0.49	$-0.41	$-0.31	$-0.52	$-0.65	$-0.60	$-0.72	$-0.75
High Forecast	$0.43	$0.24	$0.24	$-0.03	$0.30	$0.16	$0.29	$0.13	$0.41	$0.12	$0.10	$-0.06	$0.11	$-0.05	$-0.12	$-0.28	$-0.23	$-0.47	$-0.55	$-0.63	$-0.36	$-0.43	$-0.49	$-0.41	$-0.31	$-0.52	$-0.65	$-0.60	$-0.72	$-0.75
Low Forecast	$0.42	$0.23	$0.23	$-0.03	$0.29	$0.16	$0.28	$-0.17	$0.20	$0.11	$0.10	$-0.06	$0.02	$-0.05	$-0.12	$-0.29	$-0.24	$-0.47	$-0.55	$-0.63	$-0.36	$-0.43	$-0.49	$-0.41	$-0.31	$-0.52	$-0.65	$-0.60	$-0.72	$-0.75
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.56%	1.27%	0.66%	-0.04%	0.73%	0.86%	0.79%	0.95%	0.89%	1.20%	1.40%	0.94%	0.46%	0.83%	0.72%	1.05%	1.19%

According to 8 Wall Street analysts, Axonics's projected average Quarter EPS for Dec 23 is $0.06, with a low estimate of $0.02 and a high estimate of $0.11. This represents a -19.16% decrease compared to AXNX previous annual EPS of $0.08 (Sep 23).

Axonics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
NNOX	Nano-X Imaging	-	-	192.21%	Buy
IART	Integra LifeSciences	-	-	86.96%	Sell
LUNG	Pulmonx	-	-	85.83%	Buy
IRTC	iRhythm	-	-	63.96%	Buy
SIBN	SI-BONE	-	-	62.73%	Buy
KIDS	OrthoPediatrics	-	-	49.60%	Buy
NPCE	NeuroPace	-	-	43.11%	Buy
LIVN	LivaNova	-	-	36.36%	Buy
CNMD	CONMED	-	-	33.87%	Buy
BRKR	Bruker	-	-	31.18%	Buy
OFIX	Orthofix Medical	-	-	28.48%
MDT	Medtronic	-	-	27.34%	Hold
ITGR	Integer	-	-	1.56%	Buy
AXNX	Axonics	-	-	0.03%	Buy
GKOS	Glaukos	-	-	-12.35%	Buy

AXNX Forecast FAQ

Is Axonics a good buy?

Yes, according to 6 Wall Street analysts, Axonics (AXNX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 66.67% of AXNX's total ratings.

What is AXNX's price target?

Axonics (AXNX) average price target is $71 with a range of $71 to $71, implying a 0.03% from its last price of $70.98. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Axonics stock go up soon?

According to Wall Street analysts' prediction for AXNX stock, the company can go up by 0.03% (from the last price of $70.98 to the average price target of $71), up by 0.03% based on the highest stock price target, and up by 0.03% based on the lowest stock price target.

Can Axonics stock reach $110?

AXNX's average twelve months analyst stock price target of $71 does not support the claim that Axonics can reach $110 in the near future.

What are Axonics's analysts' financial forecasts?

Axonics's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $538.79M (high $543.25M, low $532.74M), average EBITDA is $-210M (high $-208M, low $-212M), average net income is $35.51M (high $44.85M, low $28.4M), average SG&A $846.13M (high $853.13M, low $836.63M), and average EPS is $0.695 (high $0.878, low $0.556). AXNX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $623.46M (high $628.61M, low $616.45M), average EBITDA is $-244M (high $-241M, low $-246M), average net income is $44.12M (high $44.63M, low $43.44M), average SG&A $979.09M (high $987.18M, low $968.09M), and average EPS is $0.864 (high $0.874, low $0.85).

Did the AXNX's actual financial results beat the analysts' financial forecasts?

Based on Axonics's last annual report (Dec 2023), the company's revenue was $366.38M, beating the average analysts forecast of $347.8M by 5.34%. Apple's EBITDA was $-26.057M, missing the average prediction of $-138M by -81.10%. The company's net income was $-6.088M, missing the average estimation of $-35.409M by -82.81%. Apple's SG&A was $235.32M, missing the average forecast of $502.18M by -53.14%. Lastly, the company's EPS was $-0.0001, missing the average prediction of $-0.391 by -99.97%. In terms of the last quarterly report (Sep 2023), Axonics's revenue was $93.1M, beating the average analysts' forecast of $89.59M by 3.91%. The company's EBITDA was $-687K, missing the average prediction of $-35.003M by -98.04%. Axonics's net income was $3.93M, missing the average estimation of $-2.608M by -250.61%. The company's SG&A was $59.32M, missing the average forecast of $140.7M by -57.84%. Lastly, the company's EPS was $0.0798, missing the average prediction of $-0.051 by -256.32%